Claire Clelland, MD, PhD
Assistant Adjunct Professor
Fields of Interest:
The Clelland laboratory aims to develop cures for dementia and related neurodegenerative diseases. She is focused on monogenic causes of frontotemporal dementia and amyotrophic lateral sclerosis, such as mutations in the C9orf72 gene. She and her team develop CRISPR gene editing approaches in relevant cell types derived from human iPSCs and are working to develop better cell model systems of disease.
Publications: